ReShape LifesciencesStock Price and Value Analysis

Should you buy ReShape Lifesciences stock? (NasdaqCM:ETRM). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company has stable growth.
  • This stock looks overpriced.
  • This company is not making money.
  • This company is less known than others.
  • This company pays no dividend.

Inside the ETRM Numbers

ETRM Price
(ReShape Lifesciences stock price per share)
$2.05
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Medical Appliances & Equipment stocks
[?] Cash Yield -75.69%
[?] Free Cash Flow Jitter 24%

Is ReShape Lifesciences Stock on Sale?

Based on our analysis, we believe that you should not buy ReShape Lifesciences right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ETRM Stock?

Does ReShape Lifesciences have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.